Antithrombin III
[ Home ] [ Up ] [ Schools ] [ Supplement Tests ] [ Request Letter ] [ Sample Release ] [ Suggestions ] [ Risks ] [ Recommended D Levels ] [ Onset Conditions ] [ Provigil ] [ Other Tests ] [ Ordering Piracetam ] [ No ISAC ] [ Medical Release ] [ Metformin ] [ Lupus anticoagulant ] [ MCS Dysfunction ] [ Malabsorbtion ] [ Relevant Experience ] [ Literature ] [ Lp(a) ] [ Lupus Antibodies ] [ Light Sensitivity ] [ Introduction ] [ Legal Issues ] [ Lapp ] [ Kutapressin ] [ Hughes Syndrome Testing ] [ Ancrod ] [ Experience ] [ Herxheimer ] [ Increasing Aldosterone ] [ Insomnia ] [ Infections ] [ Hypoxia ] [ New Page 1 ] [ Adrenal Connection ] [ Clopidogrel ] [ Coagulation ] [ Epidemics ] [ Anticoagulants ] [ Deficiencies ] [ EBV ] [ Dosing Protocols ] [ Disabilities ] [ Chelation ] [ Cheap Help ] [ Dave Berg ] [ Cheney ] [ Clinical Tests ] [ Circulation ] [ Berg ] [ Antibodies ] [ Antihistamines ] [ Antimalarials ] [ CFS Dysfunctions ] [ Candida ] [ Cacosmia ] [ Books ] [ Bananas ] [ APS-Hughes ] [ Antivirals ] [ Antithrombin III ] [ Angiotensin Receptor Blockers ] [ Anticoagulation ] [ Physicians ] [ Alopecia ] [ Allergies ]

Antithrombin III (AT)

• Acts as an anticoagulant by directly binding and inactivating the serine proteases (Factors XIa, IXa, Xa, and Thrombin).
• Recognized as an illness in 1965

Treatment

• Heparin
• Warfarin
• AT Concentrates

Enter your search terms

Web lassesen.com PubMed emedicine.com Submit search form

Home

Original 2001 WebSite as PDF for download

Looking for something, look in the Contents or do a Site Search